Tag: SONNET

Summary:Starkey and Med-El have partnered to launch DualSync, a bimodal streaming solution enabling seamless audio streaming from Apple devices to compatible hearing aids and cochlear implants starting July 1, 2025. Key Takeaways: Seamless Integration: DualSync allows synchronized streaming to both Starkey hearing aids and Med-El cochlear implants, enhancing the listening experience for bimodal users. Device Compatibility: The solution supports Starkey Edge AI and Genesis AI hearing aids and Med-El Sonnet and Rondo processors, with future compatibility planned. Shared Vision: The collaboration emphasizes user-centered innovation, aiming to improve accessibility, sound quality, and daily communication for people with complex hearing needs. Global hearing technology companies Starkey and Med-El are collaborating to introduce DualSync, a bimodal streaming partnership enabling Apple technology to seamlessly stream to compatible Starkey hearing aids and Med-El cochlear implants. This partnership brings together the strength of Starkey’s hearing aids with the innovation behind Med-El’s cochlear implants to create a seamless and unified wireless audio experience for people who rely on both technologies. https://hearingreview.com/hearing-products/accessories/assistive-technologies/starkey-partners-with-lg-on-tv-auracast-streaming Beginning July 1, 2025, Starkey Edge AI and Genesis AI hearing aids and Med-El Sonnet 3, Sonnet 2, Sonnet, and Rondo 3 audio processors will be compatible for bimodal streaming. The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies. DualSync technology is designed to provide seamless audio connectivity and synchronized sound from compatible smartphones and media devices, to empower users with more natural, connected hearing. https://hearingreview.com/hearing-products/implants-bone-conduction/cochlear-implants/med-el-usa-offers-free-year-subscription-to-meludia-music-training “Hearing loss takes many forms and, in some cases, multiple technologies are required for the best outcome of the patient,” says Brandon Sawalich, president and CEO of Starkey. “Today, two global tech leaders are combining world-class innovations to connect more people back to the things they love most. Partnering with Med-El reflects our shared commitment to delivering excellence without exception.” “By uniting two leading technologies, we are delivering a global solution that gives bimodal users effortless connectivity, clearer sound, and greater control in their daily lives,” adds Dr Ingeborg Hochmair, co-founder and CEO of Med-El. “Our shared goal is simple: to make it easier for people everywhere to hear, communicate, and engage with the world—using the most advanced technology available.” According to the companies, this collaboration reflects a shared commitment to patient-first innovation, personalized care, and expanding access to the latest in hearing technology available to users worldwide. For more information, visit www.starkey.com or www.medel.com.

Tag: SONNET

All

Starkey, Med-El Partner on DualSync for CI Connectivity

MED-EL Announces AudioLink Voucher Option and Sonnet Swap Program

MED-EL Announces FDA Approval of RONDO 2 Cochlear Implant Audio Processor

MED-EL Launches ASM 2.0 Features for Sonnet and Sonnet EAS Audio Processors

Electric Acoustic Stimulation Hearing Implant Gains FDA Approval

FDA Approves Waterproof Cover, Rechargeable Options for Audio Processors

FDA Approves MED-EL’s Sonnet Audio Processor and Software

All

Sorry, No Posts Found

All

Sorry, No Posts Found

Sorry, No Posts Found

The Hearing Review

Our Parent Company

Key Resources

Helpful Links